After a delay, the FDA has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately ...

The key opinion leader discusses how criteria for assisted reproductive technology (ART) coverage are established, including stepwise approaches and considerations for mixed protocols, while ...

Jeffrey Dunn, Pharm.D., MBA, discusses how comparison trials for different assisted reproductive technologies (ARTs) are necessary to evaluate their relative efficacy, safety and cost-effectiveness, ...

The Democrats have expanded the program under the Affordable Care Act. Republicans have proposed cuts in federal funding and work requirements.

KarXT — now with the brand name Cobenfy— is expected to be available in October with a list price of about $22,500 annually. The drug represents a new way to treat adults with schizophrenia.

Neither party wants to be perceived as threatening Medicare. The Biden administration has taken steps to reduce payment to ...

Employment satisfaction, sleep quality and lack of physical movement were all tied to vitality levels, survey results show.

The Phase I/II trials for rare forms of hereditary blindness further confirmed the potential for gene therapy treatments of ...

Clinical data suggests an imbalance in vaso-occlusive crises and fatal events that require further assessment, and the company said it will provide updates in the future.

The patient panels of physicians underrepresented in medicine (URiM) showed that they had greater odds of being a Medicaid provider than White family physicians.

The FDA approved IntraBio Inc.'s Aqneursa (levacetylleucine) yesterday for the treatment of ultra rare neurodegenerative ...

A study found omitting a course of antibiotic prophylaxis was non-inferior to the routinely administering antibiotics in ...